Covered recipient · General Payments record
BARBARA M EZELL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$179.48
- Reported across 11 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $166.09 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $50.35 | 3 |
| Acerta Pharma LLC | $48.15 | 3 |
| Lilly USA, LLC | $39.87 | 2 |
| Amgen Inc. | $14.26 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.26 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117550467 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.98 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105440998 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.12 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105660588 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.05 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104722245 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.46 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118092804 | CMS |
| Lilly USA, LLC | $19.51 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135540617 | CMS |
| Lilly USA, LLC | $20.36 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135552411 | CMS |
| Novo Nordisk Inc | $17.99 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100520015 | CMS |
| Novo Nordisk Inc | $15.29 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100255490 | CMS |
| Novo Nordisk Inc | $17.07 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100506577 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.